Now Approved: U.S. FDA approves product to reduce the incidence of catheter-related bloodstream infections (CRBSIs) under special pathway for patients receiving hemodialysis.

CorMedix Inc. to Report Fourth Quarter 2022 Financial Results and Provide a Corporate Update

May 3, 2023